Biochemical Biomarkers and Neurodegenerative Diseases
In this book, we collected scientific articles, including reviews and research articles, showcasing the lastest literature on the importance of biochemical biomarkers in the management of neurodegenerative diseases, from screening to diagnosis, prognosis, and treatment.
Saved in:
| Other Authors: | |
|---|---|
| Format: | Book Chapter |
| Published: |
Basel, Switzerland
MDPI - Multidisciplinary Digital Publishing Institute
2021
|
| Subjects: | |
| Online Access: | Get Fullteks DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 03200naaaa2200985uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_76661 | ||
| 005 | 20220111 | ||
| 020 | |a books978-3-0365-1721-6 | ||
| 020 | |a 9783036517223 | ||
| 020 | |a 9783036517216 | ||
| 024 | 7 | |a 10.3390/books978-3-0365-1721-6 |c doi | |
| 041 | 0 | |a English | |
| 042 | |a dc | ||
| 072 | 7 | |a M |2 bicssc | |
| 072 | 7 | |a PSAN |2 bicssc | |
| 100 | 1 | |a Ciaccio, Marcello |4 edt | |
| 700 | 1 | |a Ciaccio, Marcello |4 oth | |
| 245 | 1 | 0 | |a Biochemical Biomarkers and Neurodegenerative Diseases |
| 260 | |a Basel, Switzerland |b MDPI - Multidisciplinary Digital Publishing Institute |c 2021 | ||
| 300 | |a 1 electronic resource (156 p.) | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a In this book, we collected scientific articles, including reviews and research articles, showcasing the lastest literature on the importance of biochemical biomarkers in the management of neurodegenerative diseases, from screening to diagnosis, prognosis, and treatment. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Medicine |2 bicssc | |
| 650 | 7 | |a Neurosciences |2 bicssc | |
| 653 | |a GLUT3 | ||
| 653 | |a cerebral ischemia | ||
| 653 | |a MCAO | ||
| 653 | |a resveratrol | ||
| 653 | |a astrocytes | ||
| 653 | |a AMPK | ||
| 653 | |a amyotrophic lateral sclerosis | ||
| 653 | |a GSK3β | ||
| 653 | |a neurodegenerative disease | ||
| 653 | |a PD | ||
| 653 | |a Arylsulfatase A | ||
| 653 | |a lysosomes | ||
| 653 | |a GWAS | ||
| 653 | |a Gaucher's disease | ||
| 653 | |a prognostic biomarker | ||
| 653 | |a focused ultrasound | ||
| 653 | |a MR-guided focused ultrasound | ||
| 653 | |a high-intensity focused ultrasound ablation | ||
| 653 | |a magnetic resonance imaging | ||
| 653 | |a image quality | ||
| 653 | |a stereotaxic techniques | ||
| 653 | |a essential tremor | ||
| 653 | |a Alzheimer's disease | ||
| 653 | |a amyloid precursor protein | ||
| 653 | |a Tyr682 residue | ||
| 653 | |a YENPTY motif | ||
| 653 | |a Fyn tyrosine kinase | ||
| 653 | |a amyloid beta | ||
| 653 | |a ALS | ||
| 653 | |a biomarker | ||
| 653 | |a beta amyloid | ||
| 653 | |a AD | ||
| 653 | |a biomarkers | ||
| 653 | |a SARS-CoV-2 | ||
| 653 | |a neuroinflammation | ||
| 653 | |a neurodegenerative nisease | ||
| 653 | |a nervous system | ||
| 653 | |a Alzheimer's Disease | ||
| 653 | |a Vitamin D | ||
| 653 | |a 25(OH)D levels | ||
| 653 | |a Vitamin D deficiency | ||
| 653 | |a inherited neuromuscular disorders | ||
| 653 | |a rare diseases | ||
| 653 | |a multiple sclerosis | ||
| 653 | |a genetic | ||
| 653 | |a polymorphisms | ||
| 653 | |a FOXP3 | ||
| 653 | |a GATA3 | ||
| 653 | |a vitamin D | ||
| 653 | |a neuromelanin | ||
| 653 | |a nigrosome-1 | ||
| 653 | |a iron | ||
| 653 | |a radiomics | ||
| 653 | |a neurodegenerative diseases | ||
| 653 | |a Parkinson's disease | ||
| 653 | |a parkinsonian disorders | ||
| 653 | |a n/a | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/4108 |7 0 |z Get Fullteks |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/76661 |7 0 |z DOAB: description of the publication |